Overview Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit Status: Recruiting Trial end date: 2021-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to assess the efficacy and safety of Proxalutamide as a treatment for COVID-19 patients in the intensive care unit Phase: Phase 3 Details Lead Sponsor: Applied Biology, Inc.